Controlling pertussis: how can we do it? A focus on immunization

被引:18
作者
Martinon-Torres, Federico [1 ,2 ]
Heininger, Ulrich [3 ]
Thomson, Angus [4 ]
von Koenig, Carl Heinz Wirsing [5 ]
机构
[1] Hosp Clin Univ Santiago, Translat Pediat & Infect Dis, Santiago De Compostela, Spain
[2] Univ Santiago, Inst Invest Sanitaria Santiago, Genet Vaccines & Infect Dis Res Grp GENVIP, Santiago De Compostela, Spain
[3] Univ Basel Childrens Hosp UKBB, Pediat Infectiol & Vaccinat, Basel, Switzerland
[4] Sanofi Pasteur, Vaccine Confidence & Coverage, Publ Affairs, Lyon, France
[5] HELIOS Klinikum Krefeld, Krefeld, Germany
关键词
Acellular pertussis vaccine; Bordetella pertussis; vaccine hesitancy; vaccine schedule; whole-cell pertussis vaccine; HEALTH-CARE WORKERS; BORDETELLA-PERTUSSIS; INFANT PERTUSSIS; PREGNANT-WOMEN; VACCINATION COVERAGE; MATERNAL PERTUSSIS; MASS VACCINATION; TETANUS; IMPACT; EPIDEMIOLOGY;
D O I
10.1080/14760584.2018.1445530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Pertussis is a highly contagious disease of the respiratory tract which is caused by the bacterium Bordetella pertussis and is most severe in those <1year of age. A vaccine against pertussis, introduced in the 1950's, led to a significant decrease in incidence of the disease, but recent increases in outbreaks have been attributed to insufficient vaccine uptake, suboptimal protection conferred by vaccines, and waning immunity after immunization.Areas covered: In this review we discuss the major challenges for controlling pertussis, and what we believe the best strategies are to overcome these challenges, focusing on immunization against pertussis in Europe, but with recommendations that are relevant worldwide.Expert commentary: To provide maximum vaccine coverage we propose a schedule that incorporates immunization of infants, preschoolers, adolescents, adults, and pregnant women. Uptake of vaccines may also vary between populations due to a variety of causes, including hesitancy to vaccinate, so any national strategy to control pertussis should also include sustaining public and healthcare provider confidence in vaccination. Addressing and improving regional variations in surveillance will also help better monitor annual incidence and outbreaks. Looking towards the future, the development of new pertussis vaccines with longer duration of protection would be advantageous.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 88 条
[1]   Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women [J].
Agricola, Eleonora ;
Gesualdo, Francesco ;
Alimenti, Lia ;
Pandolfi, Elisabetta ;
Carloni, Emanuela ;
D'Ambrosio, Angelo ;
Russo, Luisa ;
Campagna, Ilaria ;
Ferretti, Beatrice ;
Tozzi, Alberto E. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (08) :1982-1988
[2]   Timeliness of childhood vaccinations in 31 low and middle-income countries [J].
Akmatov, Manas K. ;
Mikolajczyk, Rafael T. .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2012, 66 (07)
[3]   Asymptomatic transmission and the resurgence of Bordetella pertussis [J].
Althouse, Benjamin M. ;
Scarpino, Samuel V. .
BMC MEDICINE, 2015, 13
[4]   Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction [J].
Amirthalingam, Gayatri ;
Campbell, Helen ;
Ribeiro, Sonia ;
Fry, Norman K. ;
Ramsay, Mary ;
Miller, Elizabeth ;
Andrews, Nick .
CLINICAL INFECTIOUS DISEASES, 2016, 63 :S236-S243
[5]   Effectiveness of maternal pertussis vaccination in England: an observational study [J].
Amirthalingam, Gayatri ;
Andrews, Nick ;
Campbell, Helen ;
Ribeiro, Sonia ;
Kara, Edna ;
Donegan, Katherine ;
Fry, Norman K. ;
Miller, Elizabeth ;
Ramsay, Mary .
LANCET, 2014, 384 (9953) :1521-1528
[6]   Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee Approved by the National Vaccine Advisory Committee on September 20, 2016 [J].
Bok, Karin .
PUBLIC HEALTH REPORTS, 2017, 132 (03) :271-284
[7]  
[Anonymous], 2017, IMM COV FACT SHEET
[8]   Effectiveness of pertussis vaccines for adolescents and adults: case-control study [J].
Baxter, Roger ;
Bartlett, Joan ;
Rowhani-Rahbar, Ali ;
Fireman, Bruce ;
Klein, Nicola P. .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[9]   Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001 [J].
Bisgard, KM ;
Rhodes, P ;
Connelly, BL ;
Bi, DL ;
Hahn, C ;
Patrick, S ;
Glodé, MP ;
Ehresmann, KR .
PEDIATRICS, 2005, 116 (02) :E285-E294
[10]  
Bödeker B, 2015, BUNDESGESUNDHEITSBLA, V58, P174, DOI 10.1007/s00103-014-2097-y